AURA 2023 includes data and analyses from 2020–2022 (primarily 2020–2021) from various sources and reports on patterns and trends in antimicrobial use and appropriateness and antimicrobial resistance (AMR) in Australian acute and community healthcare settings.

This complete version of the Opioid Analgesic Stewardship in Acute Pain Clinical Care Standard describes what each quality statement means for patients and their families, clinicians, and health service organisations, and provides indicators for local monitoring. It includes information about using clinical care standards, and the background and evidence sources for this standard.

The Commission is seeking an Ongoing EL2 Director, National Standards.

Information on this vacancy and how to apply can be found in the link below. Applications for this role will close 11.59pm Australian Eastern Daylight Time (AEDT) Wednesday 14 January 2026.

Questions about the role can be directed to Principle Consultant, Lynette Taylor on 0431 293 861. 

This Easy Read resource will help people with intellectual disability and cognitive impairment understand information about their medicine. This includes the risks when using more than five medicines, known as polypharmacy. 

This Easy Read resource will help people with intellectual disability and cognitive impairment understand transitions of care and what information should be given to their new health service. 

This Easy Read resource will help people with intellectual disability and cognitive impairment understand how health workers can support people with intellectual disability well. 

This quarterly update includes data submitted to CARAlert for the reporting period 1 July to 30 September 2025. These data support the prevention and control of critical antimicrobial resistances.

To explore the latest data, visit the CARAlert Data Explorer.